Jonsson Comprehensive Cancer Center


High school student and aspiring baseball player Nick Hurtado discusses his experience battling bone cancer with "CBS Sports Center." With the support of his high school league and the efforts of UCLA's Dr. Noah Federman, Hurtado is beating the odds against bone cancer.


Leukemia survivor Kevin Williams gets help from two clinical trials at UCLA's Jonsson Comprehensive Cancer Center in his fight against cancer.


Dr. David Dawson, a pancreatic cancer researcher with UCLA's Jonsson Comprehensive Cancer Center who received a 2008 Career Development Award


In an exciting breakthrough, scientists at UCLA's Jonsson Comprehensive Cancer Center recently reported an encouraging increase in progression-free survival (or PFS, the length of time a patient is on treatment without tumor growth) for patients with HER2-negative breast cancer, a particularly aggressive form of the disease. In this informative video, lead researcher Dr. Richard Finn explains the positive results of this pioneering study and the possibilities it opens up for future breast cancer treatments.


UCLA's Jonsson Comprehensive Cancer Center is among the nation's top 10 cancer centers (US News & World Report). The JCCC has established an international reputation for pioneering the development of revolutionary targeted therapies.


Plastic surgery is a medical specialty concerned with the correction or restoration of form and function. Though cosmetic or aesthetic surgery is the best-known kind of plastic surgery, most plastic surgery is not cosmetic.


For more information on Dr. Timothy Cloughesy's research or the UCLA Department of Neurology Brain Tumor Program please go to


Kevin Carlberg overcame a brain tumor (glioblastoma) thanks to a dendritric cell vaccine developed at UCLA's Jonsson Comprehensive Cancer Center and the care of his physician, Dr. Linda Liau.

UPDATE 8/31/2009: Kevin Carlberg suffered a recurrence of his cancer and, despite treatment, he passed away on Saturday, August 29, 2009. Through his participation in a clinical trial at UCLA's Jonsson Comprehensive Cancer Center, Carlberg lived about four times longer than the average glioblastoma patient. His participation also helped move cancer research forward. We thank him.